According to a new report Asia Pacific Intragastric Balloon Market, published by KBV research, the Asia Pacific Intragastric Balloon Market would witness market growth of 13.7% CAGR during the forecast period (2020-2026).
The China market dominated the Asia Pacific Saline Filled Intragastric Balloon Market by Country in 2019, and would continue to be a dominant market till 2026. The Japan market is experiencing a CAGR of 14.3% during (2020 - 2026). Additionally, The India market is poised to grow at a CAGR of 14.3% during (2020 - 2026).
The Single market dominated the South Korea Intragastric Balloon Market by Type in 2019, thereby, achieving a market value of $1012.4 Thousands by 2026. The Dual market is exhibiting a CAGR of 14.8% during (2020 - 2026). Additionally, The Triple market is estimated to grow with highest CAGR of 14.9% during (2020 - 2026).
The Saline Filled market dominated the Singapore Intragastric Balloon Market by Filling Material in 2019, growing at a CAGR of 14 % during the forecast period. The Gas Filled market is expected to witness highest CAGR of 15.2% during (2020 - 2026).
Structural Insights: https://www.kbvresearch.com/asia-pacific-intragastric-balloon-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Sientra, Inc. (Silimed, Inc.), Apollo Endosurgery, Inc., Obalon Therapeutics, Inc., ReShape Lifesciences Inc., Allurion Technologies, Inc., Helioscopie SA (Sante Actions Group), Districlass Medical SA, Spatz FGIA, Inc., Duomed Group (Life Partners Europe), Medsil
By Administration
By Type
By Filling Material
By End Use
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
